Bactedene

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bactedene

Quick Facts

Property Description
Active Ingredient Povidone Iodine (PVP-I)
Dosage Forms Solution, Ointment, Cream, Gel
Pharmacological Class Antiseptics and Germicides
Common Purpose Topical Disinfection / Skin Infection Prevention
Origin Synthetic (Iodine complexed with Polymer)

What Type of Medicine is Bactedene?

Bactedene is a topical anti-infective medicine whose active ingredient is Povidone Iodine (PVP-I), placing it within the Antiseptics and Germicides pharmacological class. It is intended only for external use on the skin and mucous membranes, often positioned for general household first aid. Povidone Iodine is classified as an essential medicine, confirming its fundamental role as a reliable sanitizing agent in healthcare systems.

Composition: Povidone Iodine as a Synthetic Iodophor

The active component, Povidone Iodine, is a single-ingredient product chemically categorized as an iodophor, where active elemental iodine is bound to the synthetic polymer, polyvinylpyrrolidone (Povidone). In this chemical configuration, the polymer acts as a stabilizing agent. This complex allows for the slow, controlled liberation of the active agent, free iodine, which minimizes potential tissue irritation while sustaining the microbicidal activity. This formulation is commonly available as a brown-colored solution, ointment, and cream.

What is Bactedene Generally Used For?

The general purpose of Bactedene is to provide reliable topical disinfection by neutralizing a wide range of pathogens. Its action relies on the powerful oxidative disruption of microbial cells by the released iodine. This broad-spectrum efficacy is highly valued in scenarios requiring quick cleansing, such as sanitizing the area around a minor skin break to achieve skin infection prevention.

Regulatory References

  1. DailyMed: Povidone Iodine Topical Solution USP

What side effects are possible with Bactedene?

Possible Side Effects and Safety Information

Bactedene, which contains Povidone Iodine (PVP-I), has an official safety profile focused on local skin reactions and systemic risks primarily associated with excessive exposure. All safety information is derived from official governmental regulatory documents.


Dermatological and Allergic Reactions

The most commonly noted adverse reactions are local effects on the Skin and Subcutaneous Tissue. Patients may experience a transient sensation of burning or stinging upon application. Officially documented adverse reactions also include signs of hypersensitivity, such as localized pruritus (itching), erythema (redness), and contact dermatitis. Rare but serious Immune System Disorders include the risk of anaphylactic reactions.


Systemic Effects and Exposure Constraints

Systemic adverse effects are generally not expected under standard use. However, the risk of high iodine absorption leading to systemic toxicity is documented in cases of prolonged or extensive use, particularly over large-area burns or compromised skin. These systemic risks affect the Endocrine System, potentially causing thyroid dysfunction (hypo- or hyperthyroidism), and in severe cases, leading to Metabolic issues like acidosis or Renal Impairment.


Population-Specific Safety Notes

The safety profile includes restrictions for vulnerable groups. Use is contraindicated in individuals with a known hypersensitivity to iodine or pre-existing hyperthyroidism. Caution is explicitly stated for neonates and infants due to the officially noted increased risk of systemic absorption and resultant hypothyroidism.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Bactedene (Povidone Iodine) overdose centers on the risks associated with systemic absorption of iodine, typically following ingestion or excessive topical use.

Mandatory Emergency Action

Regulatory labeling specifies that if Bactedene is swallowed (ingested), immediate medical help or contact with a Poison Control Center must be sought. Urgent medical attention is required whenever severe systemic symptoms, such as acute renal failure or signs of shock, are present.

Documented Systemic Manifestations

Overdose may be associated with signs of severe iodine toxicity. Documented manifestations include acute gastrointestinal effects (abdominal pain, vomiting, bloody diarrhea) and significant neurological changes (confusion, delirium, seizures). Systemic absorption can lead to life-threatening complications, including Acute Renal Failure, Metabolic Acidosis, Hypernatremia, and abnormalities of cardiac conduction.

Management and Risk Factors

The officially documented treatment for iodine toxicity is symptomatic and supportive care, as no specific antidote is known. Close monitoring of renal, cardiac, and metabolic function is required. Regulatory information notes that patients with pre-existing kidney dysfunction or thyroid disorders, as well as neonates and infants, may be at increased risk of severe adverse outcomes due to greater sensitivity or absorption.

Therapeutic Uses of Bactedene

Bactedene (Povidone Iodine) is a topical anti-infective whose primary therapeutic purpose is to provide antiseptic support for external skin contamination and manage the potential for subsequent localized infection. The medication is commonly used as a first aid antiseptic to help manage the risk of infection in minor cuts, scrapes, and burns.

The medication's benefits are applied across domains where additional symptomatic support is needed, primarily through supporting skin cleansing and germ management for superficial skin breaks. It provides broad-spectrum anti-infective support against a wide array of surface pathogens, which is relevant when contamination may cause symptoms to intensify temporarily. Bactedene is also commonly used for pre-procedural skin preparation in clinical settings (e.g., prior to injections), which is applicable within contexts that involve acute or disruptive symptom patterns related to external microbial risk.

Quick Fact: Relief for Contamination Risk

Use Category Common Conditions Managed Patient Benefit
Antiseptic Support Minor cuts, scrapes, superficial burns, abrasions. Provides support that helps ease the overall symptom burden.
Microbial Management Surface contamination by bacteria, fungi, and viruses. Contributes to easing the overall symptom load by assisting with the management of infection risk.

Regulatory References

  1. NIH DailyMed Drug Label

Eligibility and Restrictions for Use

Who can and cannot use Bactedene?

The population eligibility for Bactedene (Povidone Iodine) is strictly governed by regulatory classifications, primarily focused on the risks associated with systemic iodine absorption. Most adults without known contraindications are approved for topical use under standard conditions.

Population Eligibility Regulatory Status (Mandatory Restrictions)
Contraindicated Populations Individuals with known hypersensitivity to iodine or povidone, and patients with manifest thyroid disorders (e.g., hyperthyroidism). Use is also contraindicated before, during, or after radioiodine therapy.
Pediatric Restrictions Use is generally contraindicated in children under two years of age for many formulations. Use on newborns and infants must be minimized or avoided due to the heightened risk of iodine-induced hypothyroidism.
Reproductive Restrictions Use during pregnancy and lactation should be kept to the absolute minimum or only when strictly indicated, as absorbed iodine can cross the placenta and enter breast milk, potentially affecting fetal or neonatal thyroid function.
Conditional Use Caution is required for regular or extensive application in elderly patients and those with existing renal insufficiency (impaired kidney function). Concurrent regular use is avoided in patients taking lithium.

The official labeling establishes these rules, with absolute prohibitions based on conditions sensitive to iodine load, while other restricted populations require careful avoidance of prolonged or large-area application.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Bactedene (Povidone Iodine) is based on chemical incompatibility, pharmacodynamic antagonism, and the systemic effects of iodine absorption, as documented in regulatory information.

Documented Interaction Restrictions

Classification Interacting Entity Interaction Description
Contraindicated Mercury-containing compounds Co-administration is prohibited due to the risk of forming caustic substances (chemical incompatibility).
Contraindicated Cellular-based skin grafts The product is incompatible with allogeneic cultured keratinocytes/fibroblasts in bovine collagen, causing degradation.
Antagonism Enzyme-containing wound preparations Concomitant use weakens the effects of both substances (e.g., collagenase products).
Additive Risk Lithium therapies Regular co-use should be avoided due to the documented risk of additive hypothyroidic effects.

Diagnostic and Population Considerations

The absorption of iodine may interfere with the results of specific diagnostic tests. Bactedene can lower the iodine uptake of the thyroid gland, potentially affecting Thyroid Function Tests (such as radioiodine diagnostics). Contamination may also lead to false-positive results for tests detecting occult blood in faeces or urine.

Population-specific warnings exist for patients with pre-existing thyroid disorders, who face an increased risk of hyperfunction. Caution is also noted for patients with renal impairment, as impaired elimination may result in the development of toxic iodine levels.

Mechanism of Action

How Bactedene Works — Mechanism of Action

The mechanism of Bactedene (Povidone Iodine, PVP-I) is based on a broad-spectrum chemical microbicidal action driven by the sustained, controlled release of elemental iodine.

Non-Specific Microbial Protein and Cellular Oxidation

This mechanism is categorized by the domain of non-specific chemical destruction. The active ingredient, free iodine ( I2), functions as a powerful oxidizing and halogenating agent that chemically attacks multiple biological targets within the microbial cell, including enzymes, proteins, and nucleotides. This rapid, widespread chemical alteration causes the irreversible denaturation and functional collapse of the cell's structure and metabolism, leading to broad-spectrum microbial cell destruction.

Regulated Release and Sustained Mechanistic Activity

The Povidone component acts as a carrier mechanism, governing the rate at which the highly reactive iodine is liberated into the local environment. This regulation is crucial as it supports the maintenance of the microbicidal agent's local concentration, supporting the chemical destruction of pathogens over time while minimizing the potential for localized high chemical reactivity.

Dosage and Administration Information

The administration of Bactedene (Povidone Iodine) is primarily topical for external use on the skin, although topical ocular application is authorized for specific pre-surgical procedures. The product is available in several official forms, including a 10% solution and various ointments or creams.

For use as a first aid antiseptic, the labeled regimen involves applying a small amount of the product to the cleaned affected area, repeating the application 1 to 3 times daily. This regimen is intended for short-term use and should generally not be continued for longer than 7 consecutive days.

The solution is typically applied full strength (undiluted) for general cutaneous antisepsis. Administration requires specific procedural steps: the area must be cleaned before application, and if the area is to be covered with a sterile dressing, the product must be allowed to dry completely beforehand. In clinical settings, care is taken to avoid pooling of the solution beneath the patient.

For specialized applications, such as pre-operative ophthalmic preparation, the solution must remain in contact with the eye for a precise duration of two minutes, followed by a required, thorough flushing with sterile saline solution to remove the product. The adult dose may be used for infants, children, and adolescents in this specific topical context.

The resulting procedural structure ensures the correct application method and temporal constraints are followed as mandated by official prescribing information.

Recent Clinical Evidence

Bactedene: Recent Clinical Evidence

The Drug's Evaluated Activity

Studies have been conducted to investigate the potential activity of Bactedene, including an inhibitory effect on a specific subtype of COX enzyme (COX-2). Research has evaluated whether this specific action is associated with changes in pain perception, and research has focused on observed changes in inflammation.


Clinical Trial Outcomes

Clinical trials were conducted to evaluate the drug's profile of outcomes in studies involving chronic musculoskeletal pain and rheumatoid arthritis.

Phase 3 Trials (Chronic Pain)

A large-scale Phase 3, randomized, double-blind, placebo-controlled trial involving 1,200 participants with chronic low back pain investigated the timeframe of onset and duration of observed changes in symptoms.

  • Primary Outcome: The mean change in the Visual Analog Scale (VAS) score over 12 weeks was documented in the study population.
  • Comparison: The compound was evaluated for its profile of outcomes compared to placebo.

Rheumatoid Arthritis Studies

The drug has been a subject of research for its potential application in the study of chronic pain associated with rheumatoid arthritis.

  • Pain & Swelling: Multiple Phase 2 studies evaluated the effect of the drug on markers of joint swelling and patient-reported pain scores over six months.

Safety Profile and Interactions

Safety studies represent a significant area of research concerning this drug.

  • Reported Side Effects: The primary side effects reported in studies were typically mild, with investigators documenting the frequency of discontinuation due to gastrointestinal upset and headache.
  • Drug-Drug Interactions: Studies evaluating potential drug interactions have noted the co-administration of this drug with other strong painkillers, specifically examining any effect on liver enzyme activity.

Frequently Asked Questions (FAQ)

Common questions about Bactedene (FAQ)

Q: How quickly does Bactedene usually start to work?

Studies on Povidone Iodine indicate that its antiseptic effect has been observed to begin rapidly, often within 30 seconds of application. Official regulatory information mentions contact times, such as one minute, which are utilized in specific clinical procedures.


Q: What is the difference between Bactedene and a similar medicine I saw advertised?

Bactedene’s active ingredient is Povidone Iodine, which is chemically classified as an iodophor. This means the active iodine is combined with a carrier molecule that provides its broad-spectrum microbicidal action by chemically oxidizing microbial cells, distinguishing it from non-iodine-based antiseptics.


Q: Is it true that Bactedene requires special monitoring?

Official product labeling includes warnings that caution and monitoring may be warranted for individuals with pre-existing thyroid disorders or renal impairment (impaired kidney function). This consideration is due to the potential for systemic iodine absorption, particularly with extensive or prolonged use.


Q: What is the approved age range for using Bactedene?

Official labeling places restrictions on use for the youngest populations, with use generally not permitted or requiring explicit caution in newborns and infants under one month of age. This is a safety measure due to the heightened, officially noted risk of iodine being absorbed, potentially affecting thyroid function.


Q: What if I'm taking Bactedene and need to have surgery?

Official documents state that the product is used for pre-operative skin antisepsis (disinfection before a procedure). However, regulatory information specifically contraindicates its use with certain materials, such as cellular-based skin grafts. A healthcare professional's procedural instructions govern its use in the surgical setting.


Q: What makes Bactedene's mechanism different from older drugs for the same condition?

Bactedene is an iodophor, meaning the active iodine is bound to a polymer (Povidone). This unique binding mechanism supports the slow, controlled release of the iodine. This controlled action sustains the microbicidal effect by regulating the availability of the active agent.


Q: Is the effect of Bactedene the same for all patients in clinical trials?

Official documentation for clinical trials reports the mean outcome (average) for the group of study participants. As with almost all medicines, the actual individual results may vary, and effectiveness can differ from one person to the next.


Q: What does the term 'contraindication' mean in relation to Bactedene?

A contraindication is a condition or circumstance that regulatory bodies determine makes it necessary to stop or completely avoid using the medicine. This is because the risk of harm to the patient is considered to outweigh any potential benefit.


Q: What research is currently happening related to Bactedene?

Official registries like ClinicalTrials.gov show that investigators continue to evaluate the potential application of Povidone Iodine. Current studies are registered to look at its use in various areas, such as nasal antisepsis for conditions like chronic rhinosinusitis.


Q: Is Bactedene known to cause drowsiness?

Official regulatory documents and adverse effect lists do not include drowsiness as one of the common side effects associated with the standard topical use of Povidone Iodine.


Q: Are there any specific foods to avoid while taking Bactedene?

No specific food interactions have been documented for topical Povidone Iodine in its regulatory labeling.


Q: Can people with liver issues use Bactedene?

Official regulatory warnings and cautions for Povidone Iodine focus primarily on thyroid and renal health. Liver impairment is not listed as a specific caution or contraindication in the official product information.


Q: Why do official documents sometimes describe Bactedene with complex scientific names?

Official documentation uses complex names, such as Polyvinylpyrrolidone-Iodine complex, to precisely describe its chemical structure. This name reflects its composition: active iodine bound to the synthetic polymer Povidone, which is necessary for clear regulatory description.


Q: Is Bactedene a controlled substance?

According to regulatory scheduling, Povidone Iodine is not classified as a controlled substance under the U.S. Controlled Substances Act and is labeled as DEA Schedule: None.


Q: How does Bactedene affect the immune system?

The medicine’s primary action is the chemical destruction of microbes, not affecting the host immune system. However, rare but serious immune system disorders, specifically severe allergic reactions like anaphylactic reactions, have been officially documented as a potential adverse effect.


Q: Are there different regulatory classifications for Bactedene in different countries?

While Povidone Iodine is globally classified as an antiseptic, its specific regulatory status, such as whether it is sold as an Over-the-Counter (OTC) drug or a Prescription (Rx) product, may vary depending on the local country or regional authority.


Q: Can Bactedene cause changes in mood or behavior?

Changes in mood or behavior are not common side effects under standard use. However, in cases of excessive absorption leading to systemic iodine toxicity and thyroid dysfunction, psychological and metabolic effects have been noted.


Q: Does Bactedene have any known interactions with alcohol?

No known drug-alcohol interactions have been documented for topical Povidone Iodine in official regulatory labeling.


Q: Is Bactedene available over the counter?

Yes, many common formulations of Povidone Iodine are classified by regulatory bodies, such as the FDA, as Over-the-Counter (OTC) drugs for general first-aid use.


Q: Is Bactedene safe to take if I have a history of heart issues?

Official regulatory documentation for topical Povidone Iodine does not list a history of heart issues as a specific caution or contraindication. The label focuses mainly on risks related to thyroid and renal health.


Q: What should I do if I notice a change in how Bactedene is affecting me?

The official labeling contains Stop Use Instructions which state that a healthcare professional should be consulted if the condition for which it is being used persists or gets worse. Guidance is also provided to seek professional advice if irritation, redness, pain, or swelling develops after application.


Q: Are there specific symptoms that Bactedene is not intended to treat?

Regulatory guidance specifies that Povidone Iodine is not intended for use on deep or puncture wounds, animal bites, or serious burns for first-aid purposes unless specifically directed by a healthcare professional.


Q: What happens if Bactedene is taken past its expiration date?

The expiration date guarantees the product's strength, quality, and purity until that time. Official guidance suggests that using an expired product may result in reduced effectiveness or the formation of degradation products with unknown safety risks.


Q: Is Bactedene a new medication or has it been around for a while?

The active ingredient, Povidone Iodine, has been in use for several decades. It was included in the FDA's Over-the-Counter (OTC) Drug Review initiated in the 1970s, establishing its long-standing presence in general medicine.


Q: Can Bactedene be taken if I have diabetes?

Diabetes is not listed as a specific caution for standard topical use. However, systemic absorption of iodine from excessive use can lead to thyroid dysfunction, which could potentially impact a patient's glycemic control.


Q: What regulatory body first approved Bactedene?

In the United States, Povidone Iodine was covered under the FDA's Over-the-Counter Drug Review process, which established its status for general use as an antiseptic.


Q: Is there a generic version of Bactedene available?

Yes, the active ingredient is Povidone Iodine, which serves as the generic name for the compound. It is widely available under various generic and store brand names globally.

How should Bactedene be stored and disposed of?

The official labeling for Bactedene (Povidone Iodine) specifies mandatory storage and handling conditions to ensure product stability and safety.

Storage Requirements

Most formulations must be stored at controlled room temperature, typically between 15 C and 30 C (59 F and 86 F). It is mandatory to protect the product from freezing and avoid excessive heat. The container must be kept tightly closed and stored away from light, ideally in the original package.

Handling and Disposal

The medicine must be kept out of the reach of children; in case of accidental ingestion, professional help should be sought immediately. Single-use products, such as ophthalmic solutions, must be discarded immediately after first use. All unused or expired product should be disposed of in accordance with local requirements for proper waste management.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bactedene found in:

A-Z Index: